Anti-VEGFR2 neutralising antibody slows the progression of multistep oral carcinogenesis.

Shirogane Y, Usami Y, Okumura M, Hirose K, Naniwa K, Ikebe K, Toyosawa S

Open source

DOI
10.1002/path.6357
Published
2024 Dec
Container
The Journal of pathology
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/path.6357,
  title = {Anti-VEGFR2 neutralising antibody slows the progression of multistep oral carcinogenesis.},
  author = {Shirogane Y and Usami Y and Okumura M and Hirose K and Naniwa K and Ikebe K and Toyosawa S},
  year = {2024},
  journal = {The Journal of pathology},
  doi = {10.1002/path.6357},
  url = {https://doi.org/10.1002/path.6357}
}

RIS

TY  - JOUR
TI  - Anti-VEGFR2 neutralising antibody slows the progression of multistep oral carcinogenesis.
AU  - Shirogane Y
AU  - Usami Y
AU  - Okumura M
AU  - Hirose K
AU  - Naniwa K
AU  - Ikebe K
AU  - Toyosawa S
PY  - 2024
JO  - The Journal of pathology
DO  - 10.1002/path.6357
UR  - https://doi.org/10.1002/path.6357
ER  - 

APA

Y, S., Y, U., M, O., K, H., K, N., K, I., & S, T. (2024). Anti-VEGFR2 neutralising antibody slows the progression of multistep oral carcinogenesis.. The Journal of pathology. https://doi.org/10.1002/path.6357

Source records